Clinical Trial Update: A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 study of BMS-663513 in combination with chemoradiation for non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BMS-663513

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: TERMINATED